Stock ABLD ABL DIAGNOSTICS
Add to a list
To use this feature you must be a member
Log inSign up

Financials ABL Diagnostics

Equities

ABLD

FR001400AHX6

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris
Other stock markets
 05:30:11 2024-04-30 am EDT 		5-day change 1st Jan Change
3.06 EUR 0.00% Intraday chart for ABL Diagnostics -3.77% -68.45%
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 6.27 8.076 7.926 2.96 3.988 29
Enterprise Value (EV) 1 4.481 0.8285 0.9562 0.6006 1.286 30.64
P/E ratio -250 x 4.98 x -126 x -33.1 x 15.5 x 206 x
Yield - - - - - -
Capitalization / Revenue 9.56 x 23.5 x - - 221,549 x 3.1 x
EV / Revenue 6.83 x 2.41 x - - 71,425 x 3.27 x
EV / EBITDA 9.48 x 7.36 x -71.7 x - - 18.8 x
EV / FCF - -3,686,693 x -3,698,029 x - 65,020,735 x -
FCF Yield - -0% -0% - 0% -
Price to Book 0.85 x 1.13 x 1.12 x 1.25 x 1.52 x 34.5 x
Nbr of stocks (in thousands) 2,006 2,006 2,006 2,006 2,006 2,006
Reference price 2 3.125 4.025 3.950 1.475 1.988 14.45
Announcement Date 5/18/18 5/2/19 6/23/20 4/23/21 5/20/22 8/1/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.6558 0.3433 - - 0.000018 9.361
EBITDA 1 0.4725 0.1125 -0.0133 - - 1.63
EBIT 1 0.1871 0.0566 -0.0693 -0.0912 -0.1026 1.069
Operating Margin 28.54% 16.49% - - -570,133.33% 11.42%
Earnings before Tax (EBT) 1 -0.0251 2.139 -0.0629 -0.0893 0.296 0.4905
Net income 1 -0.0251 1.622 -0.0629 -0.0893 0.2579 1.106
Net margin -3.83% 472.51% - - 1,432,600% 11.81%
EPS 2 -0.0125 0.8085 -0.0314 -0.0445 0.1285 0.0700
Free Cash Flow - -0.2247 -0.2586 - 0.0198 -
FCF margin - -65.45% - - 109,850% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - 7.67% -
Dividend per Share - - - - - -
Announcement Date 5/18/18 5/2/19 6/23/20 4/23/21 5/20/22 8/1/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - 1.64
Net Cash position 1 1.79 7.25 6.97 2.36 2.7 -
Leverage (Debt/EBITDA) - - - - - 1.008 x
Free Cash Flow - -0.22 -0.26 - 0.02 -
ROE (net income / shareholders' equity) -0.36% 22.3% -0.88% -1.89% 10.4% 23.6%
ROA (Net income/ Total Assets) 1.62% 0.46% -0.58% -1.19% -2.52% 7.37%
Assets 1 -1.548 349.8 10.87 7.514 -10.24 14.99
Book Value Per Share 2 3.670 3.570 3.530 1.180 1.310 0.4200
Cash Flow per Share 2 0.8900 3.610 3.470 1.180 1.350 0.0600
Capex - 0.64 - - - -
Capex / Sales - 187.69% - - - -
Announcement Date 5/18/18 5/2/19 6/23/20 4/23/21 5/20/22 8/1/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ABL DIAGNOSTICS Stock ABL Diagnostics
-68.45% 52.83M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 186B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 67.44B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 50.03B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 47.81B
HOYA CORPORATION Stock Hoya Corporation
+4.79% 41.03B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.85B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 25.82B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
+0.01% 25.01B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ABLD Stock
  4. Financials ABL Diagnostics